Table 2 Reduction of RV-GE in age groups from the pre-vaccination period to the funded vaccination period
Pre-vaccination period (2002–2005) | Intermediate period (2006–2007) | Funded vaccination period (2008–2009) | Reductiona | ||||
|---|---|---|---|---|---|---|---|
Numbers of patients (%) | Mean numbers/year (95% CI) | Numbers of patients (%) | Mean numbers/year (95% CI) | Numbers of patients (%) | Mean numbers/year (95% CI) | Decreased by (%) | |
0–11 mos | 360 (35.1) | 90.0 (80.2–99.8) | 113 (30.4) | 56.5 (44.7–68.3) | 22 (16.4) | 11.0 (2.7–19.3) | 87.8 |
12–23 mos | 300 (29.2) | 75.0 (62.8–87.2) | 125 (33.6) | 62.5 (37.6–87.4) | 55 (41.1) | 27.5 (7.4–47.6) | 63.3 |
2–5 yrs | 254 (24.8) | 63.5 (50.8–76.2) | 110 (29.6) | 55.0 (36.5–73.5) | 48 (35.8) | 24.0 (11.5–36.5) | 62.2 |
6–10 yrs | 76 (7.4) | 19.0 (15.1–22.9) | 19 (5.1) | 9.5 (8.3–10.7) | 6 (4.5) | 3.0 (1.6–4.4) | 84.2 |
11–18 yrs | 36 (3.5) | 9.0 (4.1–13.9) | 5 (1.3) | 2.5 (1.8–3.4) | 3 (2.2) | 1.0 (0.8–2.2) | 88.9 |
All | 1026 (100) | 256.5 (222.2–290.8) | 372 (100) | 186.0 (119.5–252.5) | 134 (100) | 67.0 (22.7–111.3) | 73.9 |